81 FR 61218 - Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 172 (September 6, 2016)

[Federal Register Volume 81, Number 172 (Tuesday, September 6, 2016)]
[Notices]
[Pages 61218-61219]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-21273]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-16XD]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Practice Patterns Related to Opioid Use during Pregnancy and 
Lactation--New--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    Over the past decade, the prevalence of maternal opioid use during 
pregnancy has steadily increased. The use of opioids or other 
psychoactive substances, either by illicit abuse or by nonmedical abuse 
of prescription opioids, increases the risks for health and social 
problems for both mother and infant. For example, maternal substance 
abuse during pregnancy increases the risk of preterm birth, low birth 
weight, perinatal death, and neonatal abstinence syndrome (NAS). For 
many women, and some at-risk women in particular, prenatal visits may 
be the only time they routinely see a physician. Because obstetrician-
gynecologists (OB/GYNs) are the principal health care providers for 
women, OB/GYNs are well situated to screen for substance use and to 
treat or encourage cessation of substance use during pregnancy. Thus, 
it is important

[[Page 61219]]

to understand current provider knowledge, attitudes, and practices 
regarding maternal opioid use.
    CDC, in collaboration with the American College of Obstetricians 
and Gynecologists (ACOG), plans to conduct a survey to address this gap 
in knowledge. Survey respondents will be ACOG Fellows and Junior 
Fellows who have a current medical license and are in medical practice 
focused on women's health. ACOG is separated into 11 districts, one of 
which represents OB/GYN members who are in the U.S. military. The 
remaining 10 ACOG districts correspond to geographic regions that 
encompass the entire United States and Canada. Survey invitations will 
be sent to a quasi-random sample of ACOG members in each district.
    CDC and ACOG estimate that 1,500 individuals will be contacted in 
order to obtain a study target of 600 respondents. The initial 
invitation will be distributed by email with instructions on completing 
a web-based version of the questionnaire. Three to four months after 
the initial invitation, a paper version of the questionnaire will be 
distributed to individuals who have not completed the online version. 
The estimated number of respondents for the full web-based or paper 
questionnaire is 420 and the estimated burden per response is 15 
minutes. Approximately 6 weeks after the second recruitment attempt, 
ACOG will distribute a short version of the questionnaire to any non-
responders. The estimated number of responses for the short version of 
the questionnaire is 180 and the estimated burden per response is 5 
minutes. An overall 40% response rate is expected.
    The survey will collect information about provider attitudes and 
beliefs regarding maternal opioid use, their screening and referral 
practices for pregnant or postpartum patients, barriers to screening 
and treating pregnant and postpartum patients for opioid use, and 
resources that are needed to improve treatment and referral. No 
information will be collected about individual patients. Survey 
administration and data management will be conducted by ACOG, and 
participation is voluntary. De-identified response data will be shared 
with CDC for analysis. Findings will be used to create recommendations 
for educational programs and patient care. The total estimated 
annualized burden hours are 120. There are no costs to participants 
other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
        Type of respondents                   Form name             respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
OB/GYNs caring for pregnant women..  Practice Patterns related               420               1           15/60
                                      to Opioid Use during
                                      Pregnancy and Lactation--
                                      Full survey.
                                     Practice Patterns related               180               1            5/60
                                      to Opioid Use during
                                      Pregnancy and Lactation--
                                      Short introduction and
                                      survey.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-21273 Filed 9-2-16; 8:45 am]
 BILLING CODE 4163-18-P